The US Food and Drug Administration (FDA) has approved the first video game-based treatment for attention deficit hyperactivity disorder (ADHD).
EndeavorRx, the game in question, is meant for children of 8 to 12 years old, and only for those with specific types of ADHD (primarily inattentive or combined-type ADHD who have demonstrated an attention issue). It can be acquired through prescription only, according to CNN Health.
This treatment will not be used on its own, and rather will be used in conjunction with other treatments, including therapy, medication, and educational programs.
“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health, in a press release.
According to the FDA, the game “is indicated to improve attention function as measured by computer-based testing and is the first digital therapeutic intended to improve symptoms associated with ADHD, as well as the first game-based therapeutic granted marketing authorization by the FDA for any type of condition”.
The FDA granted marketing authorization for the EndeavorRx to Akili Interactive after they reviewed five clinical studies that included over 600 children. It can now be downloaded as an app onto a mobile device.
— Akili Interactive (@AkiliLabs) June 15, 2020